Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 3
2005 4
2006 6
2007 5
2008 4
2009 2
2010 4
2011 6
2012 2
2013 5
2014 2
2015 6
2016 5
2017 6
2018 2
2019 3
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
HUS and atypical HUS.
Jokiranta TS. Jokiranta TS. Blood. 2017 May 25;129(21):2847-2856. doi: 10.1182/blood-2016-11-709865. Epub 2017 Apr 17. Blood. 2017. PMID: 28416508 Free PMC article. Review.
Complement analysis in the 21st century.
Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez de Cordoba S, Kirschfink M. Mollnes TE, et al. Among authors: jokiranta ts. Mol Immunol. 2007 Sep;44(16):3838-49. doi: 10.1016/j.molimm.2007.06.150. Mol Immunol. 2007. PMID: 17768101 Review.
Complement resistance mechanisms of streptococci.
Jarva H, Jokiranta TS, Würzner R, Meri S. Jarva H, et al. Among authors: jokiranta ts. Mol Immunol. 2003 Sep;40(2-4):95-107. doi: 10.1016/s0161-5890(03)00108-1. Mol Immunol. 2003. PMID: 12914816 Review.
Where next with atypical hemolytic uremic syndrome?
Jokiranta TS, Zipfel PF, Fremeaux-Bacchi V, Taylor CM, Goodship TJ, Noris M. Jokiranta TS, et al. Mol Immunol. 2007 Sep;44(16):3889-900. doi: 10.1016/j.molimm.2007.06.003. Mol Immunol. 2007. PMID: 17768107 Review.
New approaches to the treatment of dense deposit disease.
Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Córdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF; Dense Deposit Disease Focus Group. Smith RJ, et al. Among authors: jokiranta ts. J Am Soc Nephrol. 2007 Sep;18(9):2447-56. doi: 10.1681/ASN.2007030356. Epub 2007 Aug 5. J Am Soc Nephrol. 2007. PMID: 17675665 Free PMC article. Review.
T cell receptor diversity in the human thymus.
Vanhanen R, Heikkilä N, Aggarwal K, Hamm D, Tarkkila H, Pätilä T, Jokiranta TS, Saramäki J, Arstila TP. Vanhanen R, et al. Among authors: jokiranta ts. Mol Immunol. 2016 Aug;76:116-22. doi: 10.1016/j.molimm.2016.07.002. Epub 2016 Jul 19. Mol Immunol. 2016. PMID: 27442982
Role of Pneumococcal NanA Neuraminidase Activity in Peripheral Blood.
Syed S, Hakala P, Singh AK, Lapatto HAK, King SJ, Meri S, Jokiranta TS, Haapasalo K. Syed S, et al. Among authors: jokiranta ts. Front Cell Infect Microbiol. 2019 Jun 26;9:218. doi: 10.3389/fcimb.2019.00218. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31297339 Free PMC article.
Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases.
Lamberg T, Sipponen T, Valtanen S, Eklund KK, Mälkönen T, Aalto K, Mikola K, Kolho KL, Leinonen S, Isomäki P, Mäkinen H, Vidqvist KL, Kokko A, Huilaja L, Kyllönen M, Keskitalo P, Sard S, Vähäsalo P, Koskela R, Kröger L, Lahtinen P, Haapala AM, Korkatti K, Sokka-Isler T, Jokiranta TS; BLING Research Group. Lamberg T, et al. Among authors: jokiranta ts. Autoimmunity. 2022 Aug;55(5):275-284. doi: 10.1080/08916934.2022.2067985. Epub 2022 Apr 28. Autoimmunity. 2022. PMID: 35481450
69 results